News
DNA
10.66
+4.00%
0.41
Everpure, Fervo Energy, Charles River Laboratories And Other Big Stocks Moving Higher On Thursday
Benzinga · 2d ago
Ginkgo Bioworks Holdings, Inc. (DNA) Sees a More Significant Dip Than Broader Market: Some Facts to Know
NASDAQ · 3d ago
Weekly Report: what happened at DNA last week (0914-0918)?
Weekly Report · 5d ago
Ginkgo Bioworks (DNA) Surges 11.1%: Is This an Indication of Further Gains?
NASDAQ · 09/18 16:31
Weekly Buzz: RARE, BAYRY Win Approvals; SION Cuts Jobs, GSK Deals; AZN, RHHBY Lead
NASDAQ · 09/18 14:44
Ginkgo Bioworks Holdings, Inc. (DNA) Rises As Market Takes a Dip: Key Facts
NASDAQ · 09/16 22:15
Ginkgo Datapoints Partners With Lilly TuneLab To Link AI Models And Lab Data
NASDAQ · 09/16 15:06
Twist Bio, and Gingko rise after agreements with Lilly TuneLab
Seeking Alpha · 09/16 14:36
Ginkgo Bioworks announces partnership with Lilly TuneLab
TipRanks · 09/16 13:55
Weekly Report: what happened at DNA last week (0907-0911)?
Weekly Report · 09/14 09:31
Ginkgo Bioworks awarded up to $17.5M subcontract under ARPA-H GIVE program
TipRanks · 09/10 12:20
Weekly Report: what happened at DNA last week (0831-0904)?
Weekly Report · 09/07 09:28
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Ginkgo Bioworks Holdings (DNA) and Vericel (VCEL)
TipRanks · 09/04 11:30
Ginkgo Bioworks Holdings Price Target Maintained With a $5.00/Share by BTIG
Dow Jones · 09/04 11:12
BTIG Reiterates Sell on Ginkgo Bioworks Holdings, Maintains $5 Price Target
Benzinga · 09/04 11:01
Ginkgo Bioworks: Another Pivot, Still No Proof Of Product-Market Fit
Seeking Alpha · 09/01 19:04
Weekly Report: what happened at DNA last week (0824-0828)?
Weekly Report · 08/31 09:31
HHS said to be eyeing two new FDA deputy commissioners for technology and drugs
Seeking Alpha · 08/25 17:53
Weekly Report: what happened at DNA last week (0817-0821)?
Weekly Report · 08/24 09:31
Ginkgo Bioworks Earnings Call Balances Progress, Pressure
TipRanks · 08/23 00:18
More
Webull provides a variety of real-time DNA stock news. You can receive the latest news about Ginkgo Bioworks Holdings Inc through multiple platforms. This information may help you make smarter investment decisions.
About DNA
Ginkgo Bioworks Holdings, Inc. offers biological research and development (R&D) services on its platform and autonomous laboratory to enable its customers to bring their products to market. The Company sells tools and biological R&D services across a range of industries to government and commercial customers. Its in-house autonomous lab is available as Cloud Lab through its Datapoints and Solutions contract research services. Its single segment, namely cell engineering, provides tools and biological R&D services across a range of industries. Its cell engineering customers work with biology to discover and manufacture new products across industries such as medicine, agriculture, industrial biotechnology and government. It provides R&D services spanning genetic medicine modalities: gene therapy, cell therapy and gene editing, and RNA therapeutics. It provides a suite of microservices for product developers across industries that support bioengineers with protein engineering.